{"id":"https://genegraph.clinicalgenome.org/r/2d27e2fb-841a-40c4-bd2d-6cb0542847fav1.0","type":"EvidenceStrengthAssertion","dc:description":"The *TXNL4A* gene is located on chromosome 18 at 18p23 and encodes a highly conserved component of the U5 spliceosomal complex that is essential for U4/U6·U5 tri-snRNP assembly, cell cycle progression and pre-mRNA splicing. *TXNL4A* was first reported in relation to autosomal recessive Burn-McKeown syndrome (BMKS) in 2014 (Wieczorek et al., PMID: 25434003). BMKS is a rare multiple congenital anomaly syndrome characterized by bilateral choanal atresia associated with characteristic cranio-facial dysmorphisms and generally normal intelligence. Other phenotypes may include hearing loss, cleft lip/palate, and cardiac defects. At least 10 unique variants (promoter, missense, nonsense, frameshift) that have been reported in 14 probands in four publications (PMIDs: 25434003, 28905882, 32187816, 34713892) are included in this curation. Twelve out of the 14 probands were compound heterozygotes with a 34 bp promoter type 1 deletion (NM_006701.5:c.-222_-189del34) identified on one allele and a loss-of-function variant on the other. This gene-disease relationship is also supported by evidence of functional alteration, and an animal model in Xenopus (PMIDs: 25434003, 32735620, 35893124). In summary, there is definitive evidence to support the relationship between *TXNL4A* and autosomal recessive Burn-McKeown syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Syndromic GCEP on the meeting date 2/16/2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/2d27e2fb-841a-40c4-bd2d-6cb0542847fa","GCISnapshot":"https://genegraph.clinicalgenome.org/r/bac99de0-8f34-4166-b8ef-a5c44290281c","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/bac99de0-8f34-4166-b8ef-a5c44290281c_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-02-16T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/bac99de0-8f34-4166-b8ef-a5c44290281c_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-04-09T13:46:42.107Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bac99de0-8f34-4166-b8ef-a5c44290281c_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bac99de0-8f34-4166-b8ef-a5c44290281c_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6acc69e-92d1-4b0a-aa00-686f4586ffc3_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","rdfs:label":"Wieczorek Family BMKS001","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/f6acc69e-92d1-4b0a-aa00-686f4586ffc3","type":"Family","rdfs:label":"Wieczorek Family BMKS001","member":{"id":"https://genegraph.clinicalgenome.org/r/f1cd3c98-8db2-4638-b7df-bbb645e20101","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","rdfs:label":"BMKS001 III/1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000018.10:g.79988603_79988636del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA174996"}},{"id":"https://genegraph.clinicalgenome.org/r/c4b4fbc9-21e2-426c-b558-cc60f164605e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006701.5(TXNL4A):c.349G>T (p.Glu117Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA174997"}}],"detectionMethod":"Whole-genome microarray or MLPA analysis, Exome sequencing, WGS, Sanger sequencing","firstTestingMethod":"Chromosomal microarray","phenotypeFreeText":"Normal psychomotor development","phenotypes":["obo:HP_0000193","obo:HP_0000426","obo:HP_0000233","obo:HP_0000316","obo:HP_0000411","obo:HP_0000365","obo:HP_0012745","obo:HP_0004502","obo:HP_0000322","obo:HP_0000652"],"secondTestingMethod":"Exome sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/601c223a-5c43-459f-90d0-d926dae6ef8d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/c4b4fbc9-21e2-426c-b558-cc60f164605e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/2db8132a-a8a3-4966-8d7f-b400e69a25fc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Normal psychomotor development","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0004502","obo:HP_0000426","obo:HP_0000316","obo:HP_0000322","obo:HP_0012745","obo:HP_0000233","obo:HP_0000411","obo:HP_0000652"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/f1cd3c98-8db2-4638-b7df-bbb645e20101"}},{"id":"https://genegraph.clinicalgenome.org/r/7e83d4a5-da9c-4106-83ec-123368ce0593_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","rdfs:label":"Wieczorek Family BMKS007","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/7e83d4a5-da9c-4106-83ec-123368ce0593","type":"Family","rdfs:label":"Wieczorek Family BMKS007","member":{"id":"https://genegraph.clinicalgenome.org/r/02290f02-4282-4b3a-8c81-5f281a2b28eb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","rdfs:label":"BMKS007 II/1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/837f292f-f650-4b3c-9ec1-fb575891ba5d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"GRCh37 18q23(chr18:76841645-78077248)x1"},{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"}],"detectionMethod":"Whole-genome microarray or MLPA analysis, Sanger sequencing\n","firstTestingMethod":"Chromosomal microarray","phenotypeFreeText":"Normal psychomotor development","phenotypes":["obo:HP_0001627","obo:HP_0000316","obo:HP_0000426","obo:HP_0000411","obo:HP_0000347","obo:HP_0000233","obo:HP_0200138","obo:HP_0000365","obo:HP_0000322","obo:HP_0000652","obo:HP_0012745","obo:HP_0004322"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/6a64afa3-c007-4477-8ee7-502a00dce46d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/837f292f-f650-4b3c-9ec1-fb575891ba5d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/be1b3eb1-4460-4ec6-b5af-7aa241644254_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Normal psychomotor development","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000322","obo:HP_0000652","obo:HP_0001627","obo:HP_0200138","obo:HP_0012745","obo:HP_0000365","obo:HP_0004322","obo:HP_0000347","obo:HP_0000426","obo:HP_0000411","obo:HP_0000316"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/02290f02-4282-4b3a-8c81-5f281a2b28eb"}},{"id":"https://genegraph.clinicalgenome.org/r/176c7340-3804-4b62-acb4-31eda1859151_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32187816","rdfs:label":"Narayana family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/176c7340-3804-4b62-acb4-31eda1859151","type":"Family","rdfs:label":"Narayana family","member":{"id":"https://genegraph.clinicalgenome.org/r/a5eac559-785c-4897-bf71-24af5622c451","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32187816","rdfs:label":"Narayana P1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":43,"allele":{"id":"https://genegraph.clinicalgenome.org/r/fcd757f4-de04-4cf8-97f2-8bdabab058e7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000018.10:g.79988607_79988640del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA199691"}},"detectionMethod":"Exome sequencing, targeted dideoxy DNA sequencing and segregation analysis","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Normal intelligence","phenotypes":["obo:HP_0004502","obo:HP_0000316","obo:HP_0000426","obo:HP_0000652","obo:HP_0000494","obo:HP_0000324","obo:HP_0000272","obo:HP_0000322"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/33fa1317-5ea8-439e-ba18-6692ab6ca652_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32187816","allele":{"id":"https://genegraph.clinicalgenome.org/r/fcd757f4-de04-4cf8-97f2-8bdabab058e7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypeFreeText":"Normal intelligence","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0004502","obo:HP_0000494","obo:HP_0000426","obo:HP_0000324","obo:HP_0000652","obo:HP_0000322","obo:HP_0000272","obo:HP_0000316"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a5eac559-785c-4897-bf71-24af5622c451"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f1cd3c98-8db2-4638-b7df-bbb645e20101_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2db8132a-a8a3-4966-8d7f-b400e69a25fc","type":"EvidenceLine","dc:description":"Downgraded as this variant is a hypomorphic variant and is recurrent in multiple other patients","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2db8132a-a8a3-4966-8d7f-b400e69a25fc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reporter gene and in vivo assays showed reduced promoter activity and reduced expression of TXNL4A","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2db8132a-a8a3-4966-8d7f-b400e69a25fc_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/601c223a-5c43-459f-90d0-d926dae6ef8d","type":"EvidenceLine","dc:description":"It is predicted to escape NMD","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/601c223a-5c43-459f-90d0-d926dae6ef8d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f1cd3c98-8db2-4638-b7df-bbb645e20101"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.35},{"id":"https://genegraph.clinicalgenome.org/r/d5578b62-128d-4b95-9101-6785cbfd8bf5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ce4fe6e-0cac-4edc-815c-b385fd9b8511","type":"EvidenceLine","dc:description":"Predicted to escape NMD","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ce4fe6e-0cac-4edc-815c-b385fd9b8511_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/0fe8f0c2-c62a-47f9-8914-ff48acefd512","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006701.5(TXNL4A):c.37C>T (p.Gln13Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA175000"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c053db64-35a0-4b63-96b5-7db337d42de6","type":"EvidenceLine","dc:description":"Downgraded as it is a hypomorph and is recurrent in other patients","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c053db64-35a0-4b63-96b5-7db337d42de6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reporter gene and in vivo assays showed reduced promoter activity and reduced expression of TXNL4A","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c053db64-35a0-4b63-96b5-7db337d42de6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/d5578b62-128d-4b95-9101-6785cbfd8bf5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","rdfs:label":"BMKS002 II/1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":34,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/0fe8f0c2-c62a-47f9-8914-ff48acefd512"},{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"}],"detectionMethod":"Whole-genome microarray or MLPA analysis, Exome sequencing, WGS, Sanger sequencing\n","firstTestingMethod":"Chromosomal microarray","phenotypeFreeText":"Normal psychomotor development","phenotypes":["obo:HP_0200138","obo:HP_0000322","obo:HP_0000652","obo:HP_0000316","obo:HP_0000365","obo:HP_0000202","obo:HP_0000426","obo:HP_0012745"],"secondTestingMethod":"Whole genome shotgun sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c053db64-35a0-4b63-96b5-7db337d42de6_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5ce4fe6e-0cac-4edc-815c-b385fd9b8511_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.35},{"id":"https://genegraph.clinicalgenome.org/r/363adb10-70a7-4008-9e45-62f5d2be21e8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d45a9d06-6f5d-4cd9-8693-3895c999a5e8","type":"EvidenceLine","dc:description":"Downgraded due to homozygosity and consanguinity. Moreover this variant is a hypomorph and is recurrent in other patients","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d45a9d06-6f5d-4cd9-8693-3895c999a5e8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reporter gene and in vivo assays showed reduced promoter activity and reduced expression of TXNL4A\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d45a9d06-6f5d-4cd9-8693-3895c999a5e8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/fcd757f4-de04-4cf8-97f2-8bdabab058e7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/363adb10-70a7-4008-9e45-62f5d2be21e8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","rdfs:label":"BMKS008 pt 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/fcd757f4-de04-4cf8-97f2-8bdabab058e7"},"detectionMethod":"Whole-genome microarray or MLPA analysis, WGS, Sanger sequencing\n","firstTestingMethod":"Chromosomal microarray","phenotypes":["obo:HP_0200138","obo:HP_0000365","obo:HP_0000426","obo:HP_0000652","obo:HP_0000384","obo:HP_0000202","obo:HP_0000316","obo:HP_0000411","obo:HP_0000347","obo:HP_0000233","obo:HP_0001627","obo:HP_0012745","obo:HP_0000322","obo:HP_0000193"],"secondTestingMethod":"Whole genome shotgun sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d45a9d06-6f5d-4cd9-8693-3895c999a5e8_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/7d3e7262-dcd4-407d-b4ab-d75b76b8d3ae_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd394469-7948-4cad-9c56-5d3a3bd6febe","type":"EvidenceLine","dc:description":"The promoter type 1 del variant is a hypomorph and is recurrent in other patients, so it is scored at 0.25 pt. This proband also had an exon 3 deletion that was scored at 1.5 pt, but couldn't be entered into the GCI. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd394469-7948-4cad-9c56-5d3a3bd6febe_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reporter gene and in vivo assays showed reduced promoter activity and reduced expression of TXNL4A\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/cd394469-7948-4cad-9c56-5d3a3bd6febe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.75},{"id":"https://genegraph.clinicalgenome.org/r/7d3e7262-dcd4-407d-b4ab-d75b76b8d3ae","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","rdfs:label":"BMKS010 II/1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"detectionMethod":"Whole-genome microarray, MLPA analysis, Sanger sequencing\n","firstTestingMethod":"Chromosomal microarray","phenotypes":["obo:HP_0000652","obo:HP_0000426","obo:HP_0000316","obo:HP_0012745","obo:HP_0000233","obo:HP_0200138","obo:HP_0000202","obo:HP_0000411","obo:HP_0000322","obo:HP_0000347"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cd394469-7948-4cad-9c56-5d3a3bd6febe_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.75},{"id":"https://genegraph.clinicalgenome.org/r/a5eac559-785c-4897-bf71-24af5622c451_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33fa1317-5ea8-439e-ba18-6692ab6ca652","type":"EvidenceLine","dc:description":"Hypomorphic and is recurrent in other patients. Moreover, the family was consanguineous.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33fa1317-5ea8-439e-ba18-6692ab6ca652_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reporter gene and in vivo assays showed reduced promoter activity and reduced expression of TXNL4A\n(PMID:25434003)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/33fa1317-5ea8-439e-ba18-6692ab6ca652_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/a5eac559-785c-4897-bf71-24af5622c451"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/02290f02-4282-4b3a-8c81-5f281a2b28eb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a64afa3-c007-4477-8ee7-502a00dce46d","type":"EvidenceLine","dc:description":"1.235 Mb del incl. entire gene and 11 other genes\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a64afa3-c007-4477-8ee7-502a00dce46d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/be1b3eb1-4460-4ec6-b5af-7aa241644254","type":"EvidenceLine","dc:description":"Downgraded as this variant is a hypomorph and is recurrent in other patients","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be1b3eb1-4460-4ec6-b5af-7aa241644254_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reporter gene and in vivo assays showed reduced promoter activity and reduced expression of TXNL4A\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/be1b3eb1-4460-4ec6-b5af-7aa241644254_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/02290f02-4282-4b3a-8c81-5f281a2b28eb"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/84743f5e-6d45-4f0d-829e-aa39bf966880_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54941241-e01a-4fc6-9ba9-d62c6d6b6847","type":"EvidenceLine","dc:description":"Downgraded since it is a hypomorphic variant and is recurrent in other patients","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54941241-e01a-4fc6-9ba9-d62c6d6b6847_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reporter gene and in vivo assays showed reduced promoter activity and reduced expression of TXNL4A\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/54941241-e01a-4fc6-9ba9-d62c6d6b6847_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/0be827e9-a021-48d9-a39a-77d5421c7857","type":"EvidenceLine","dc:description":"Predicted to escape NMD but scored at 1 due to out of frame shift in reading frame","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0be827e9-a021-48d9-a39a-77d5421c7857_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/d4b7be0b-bf5e-4bac-a333-4655b068d5cf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006701.5(TXNL4A):c.131del (p.Val44AlafsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA175001"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/84743f5e-6d45-4f0d-829e-aa39bf966880","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","rdfs:label":"BMKS005 II/4","allele":[{"id":"https://genegraph.clinicalgenome.org/r/d4b7be0b-bf5e-4bac-a333-4655b068d5cf"},{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"}],"detectionMethod":"Whole-genome microarray or MLPA analysis, Exome sequencing, WGS, Sanger sequencing\n","firstTestingMethod":"Chromosomal microarray","phenotypes":["obo:HP_0000426","obo:HP_0000365","obo:HP_0012758","obo:HP_0000347","obo:HP_0012745","obo:HP_0000316","obo:HP_0001627","obo:HP_0010864","obo:HP_0000411","obo:HP_0000202","obo:HP_0000384","obo:HP_0200138"],"secondTestingMethod":"Whole genome shotgun sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/54941241-e01a-4fc6-9ba9-d62c6d6b6847_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0be827e9-a021-48d9-a39a-77d5421c7857_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.25},{"id":"https://genegraph.clinicalgenome.org/r/42815f93-00ee-41da-920c-0374f68cb427_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3378c643-8dd4-463c-8521-49b3992442ac","type":"EvidenceLine","dc:description":"4.701 Mb del incl. entire gene and 22 other genes\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3378c643-8dd4-463c-8521-49b3992442ac_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/1b7bd007-af41-4eb5-84a1-4032ab629b26","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"GRCh37 18q23(chr18:73376178-78077248)x1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0ee4abea-ff48-4782-8116-2356750bf463","type":"EvidenceLine","dc:description":"Downgraded as it is a hypomorph and is recurrent in other patients","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ee4abea-ff48-4782-8116-2356750bf463_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reporter gene and in vivo assays showed reduced promoter activity and reduced expression of TXNL4A\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0ee4abea-ff48-4782-8116-2356750bf463_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/42815f93-00ee-41da-920c-0374f68cb427","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","rdfs:label":"BMKS009 II/1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/1b7bd007-af41-4eb5-84a1-4032ab629b26"},{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"}],"detectionMethod":"Whole-genome microarray or MLPA analysis, Sanger sequencing\n","firstTestingMethod":"Chromosomal microarray","phenotypeFreeText":"Normal psychomotor development","phenotypes":["obo:HP_0000322","obo:HP_0000233","obo:HP_0000426","obo:HP_0000411","obo:HP_0200138","obo:HP_0000202","obo:HP_0000316","obo:HP_0000365","obo:HP_0000347","obo:HP_0000652","obo:HP_0012745"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/3378c643-8dd4-463c-8521-49b3992442ac_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0ee4abea-ff48-4782-8116-2356750bf463_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/b6579e3c-fc6b-4bd7-b6c7-2f083d4ce858_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49a8cc89-82d5-4b4e-9b44-25a04e5dda6f","type":"EvidenceLine","dc:description":"Not scored because this is a recurrent variant","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49a8cc89-82d5-4b4e-9b44-25a04e5dda6f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Restriction enzyme digest analysis showed no or extremely reduced mature transcript","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/49a8cc89-82d5-4b4e-9b44-25a04e5dda6f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28905882","allele":{"id":"https://genegraph.clinicalgenome.org/r/73d8222c-ccc1-4d50-a921-ff91eafb9117","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006701.5(TXNL4A):c.258-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA303804273"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/93500a06-29c4-4be3-8878-75a6196c6197","type":"EvidenceLine","dc:description":"Hypomorphic and is recurrent in other patients","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93500a06-29c4-4be3-8878-75a6196c6197_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression was reduced by ~69% in blood RNA\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/93500a06-29c4-4be3-8878-75a6196c6197_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28905882","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/b6579e3c-fc6b-4bd7-b6c7-2f083d4ce858","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28905882","rdfs:label":"Goos family 2 III.1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/73d8222c-ccc1-4d50-a921-ff91eafb9117"},{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"}],"detectionMethod":"Affymetrix 750 K microarray TXNL4A, MLPA\n","firstTestingMethod":"Chromosomal microarray","phenotypeFreeText":"asymptomatic ASD and VSD, normal psychomotor development\n","phenotypes":["obo:HP_0000347","obo:HP_0010781","obo:HP_0004502","obo:HP_0000426","obo:HP_0000540","obo:HP_0000175","obo:HP_0000384","obo:HP_0410030","obo:HP_0000652","obo:HP_0001561"],"secondTestingMethod":"PCR","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/93500a06-29c4-4be3-8878-75a6196c6197_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/49a8cc89-82d5-4b4e-9b44-25a04e5dda6f_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/c8fe6165-59d6-4937-89c1-0b672d118e3a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db3079f2-9e6f-4d77-8ec4-ff818f29bebc","type":"EvidenceLine","dc:description":"Downgraded as it is a hypomorph and is recurrent in other patients","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db3079f2-9e6f-4d77-8ec4-ff818f29bebc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reporter gene and in vivo assays showed reduced promoter activity and reduced expression of TXNL4A\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/db3079f2-9e6f-4d77-8ec4-ff818f29bebc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/80122b21-a767-4990-b431-07ab215983c0","type":"EvidenceLine","dc:description":"1.222 Mb del incl. entire gene and 11 other genes\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80122b21-a767-4990-b431-07ab215983c0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/0190dc67-c543-4c02-999e-6c0fd573ebb4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"GRCh37 18q23(chr18:76854774-78077248)x1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c8fe6165-59d6-4937-89c1-0b672d118e3a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","rdfs:label":"BMKS004 II/1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},{"id":"https://genegraph.clinicalgenome.org/r/0190dc67-c543-4c02-999e-6c0fd573ebb4"}],"detectionMethod":"Whole-genome microarray or MLPA analysis,, WGS, Sanger sequencing\n","firstTestingMethod":"Chromosomal microarray","phenotypeFreeText":"Normal psychomotor development","phenotypes":["obo:HP_0000384","obo:HP_0200138","obo:HP_0000316","obo:HP_0000347","obo:HP_0000322","obo:HP_0012745","obo:HP_0000365","obo:HP_0000411","obo:HP_0001627","obo:HP_0000202","obo:HP_0000426"],"secondTestingMethod":"Whole genome shotgun sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/db3079f2-9e6f-4d77-8ec4-ff818f29bebc_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/80122b21-a767-4990-b431-07ab215983c0_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/c17c414b-3b27-443b-a9a0-0c207a55e372_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/193dc296-f416-47eb-b041-1351472ecd01","type":"EvidenceLine","dc:description":"Hypomorphic and is recurrent in other patients.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/193dc296-f416-47eb-b041-1351472ecd01_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dual luciferase assays showed that the Type 1 promoter del reduced promoter activity to 46% ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/193dc296-f416-47eb-b041-1351472ecd01_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34713892","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/46c54231-4c0b-4feb-aa4e-3dfa9acd0055","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46c54231-4c0b-4feb-aa4e-3dfa9acd0055_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34713892","allele":{"id":"https://genegraph.clinicalgenome.org/r/f5759148-e07d-4b5f-ab8a-2707707bafde","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006701.5(TXNL4A):c.93_94del (p.His32ArgfsTer21)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580096015"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c17c414b-3b27-443b-a9a0-0c207a55e372","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34713892","rdfs:label":"Wood Family 1 proband","allele":[{"id":"https://genegraph.clinicalgenome.org/r/f5759148-e07d-4b5f-ab8a-2707707bafde"},{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"}],"firstTestingMethod":"Whole genome shotgun sequencing","phenotypes":["obo:HP_0000218","obo:HP_0004502","obo:HP_0000405","obo:HP_0000272","obo:HP_0000407","obo:HP_0000652","obo:HP_0000347","obo:HP_0000411","obo:HP_0008551","obo:HP_0040263"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/193dc296-f416-47eb-b041-1351472ecd01_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/46c54231-4c0b-4feb-aa4e-3dfa9acd0055_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.75},{"id":"https://genegraph.clinicalgenome.org/r/24c28e4f-3c5f-4f43-b478-171a820b3c1d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7df79ef-aedb-4680-a155-bcca9d6b96ba","type":"EvidenceLine","dc:description":"0.484 Mb del incl. entire gene and 7 other genes\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7df79ef-aedb-4680-a155-bcca9d6b96ba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/ad822235-2547-46da-b36f-8e36e6eb00d6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"GRCh37 18q23(chr18:77421290-77904990)x1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/bc04c118-deac-4eaa-8bba-16c086de21fe","type":"EvidenceLine","dc:description":"Downgraded since it is a hypomorph and is recurrent in other patients","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc04c118-deac-4eaa-8bba-16c086de21fe_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reporter gene and in vivo assays showed reduced promoter activity and reduced expression of TXNL4A\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bc04c118-deac-4eaa-8bba-16c086de21fe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/24c28e4f-3c5f-4f43-b478-171a820b3c1d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","rdfs:label":"BMKS006 II/1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},{"id":"https://genegraph.clinicalgenome.org/r/ad822235-2547-46da-b36f-8e36e6eb00d6"}],"detectionMethod":"Whole-genome microarray or MLPA analysis, Sanger sequencing\n","firstTestingMethod":"Chromosomal microarray","phenotypeFreeText":"Normal psychomotor development","phenotypes":["obo:HP_0000316","obo:HP_0000384","obo:HP_0004502","obo:HP_0000426","obo:HP_0000322","obo:HP_0012745"],"secondTestingMethod":"Whole genome shotgun sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/bc04c118-deac-4eaa-8bba-16c086de21fe_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a7df79ef-aedb-4680-a155-bcca9d6b96ba_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/bcfd3547-4f39-441a-be54-91b59b998578_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0d4fc34-ce6d-4ea5-8dab-4da0a3d56546","type":"EvidenceLine","dc:description":"Splicing variants maxed at 1.5 pts regardless of functional evidence","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0d4fc34-ce6d-4ea5-8dab-4da0a3d56546_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Minigene splicing assays showed that c.258-3C>G led to complete skipping of the TXNL4A final exon","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e0d4fc34-ce6d-4ea5-8dab-4da0a3d56546_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34713892","allele":{"id":"https://genegraph.clinicalgenome.org/r/4936ab8b-a5af-4394-aa0b-1d8df78451e9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006701.5(TXNL4A):c.258-3C>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580096013"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/708463c7-d607-4733-942f-282323cbeada","type":"EvidenceLine","dc:description":"Hypomorphic and is recurrent in other patients.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/708463c7-d607-4733-942f-282323cbeada_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dual luciferase assays showed that the Type 1 promoter del reduced promoter activity to 46% ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/708463c7-d607-4733-942f-282323cbeada_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34713892","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/bcfd3547-4f39-441a-be54-91b59b998578","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34713892","rdfs:label":"Wood Family 2 proband","allele":[{"id":"https://genegraph.clinicalgenome.org/r/4936ab8b-a5af-4394-aa0b-1d8df78451e9"},{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"}],"firstTestingMethod":"Whole genome shotgun sequencing","phenotypes":["obo:HP_0410030","obo:HP_0000453","obo:HP_0000272","obo:HP_0000405","obo:HP_0000377","obo:HP_0008551","obo:HP_0000494"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e0d4fc34-ce6d-4ea5-8dab-4da0a3d56546_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/708463c7-d607-4733-942f-282323cbeada_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.75},{"id":"https://genegraph.clinicalgenome.org/r/adb8e5af-4829-4d9e-9897-154b4c27370e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc838c5d-8ef0-4ac4-9ec7-62079f9354c6","type":"EvidenceLine","dc:description":"Downgraded as it is a hypomorph and is recurrent in other patients","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc838c5d-8ef0-4ac4-9ec7-62079f9354c6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression was reduced by ~69% in blood RNA","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/cc838c5d-8ef0-4ac4-9ec7-62079f9354c6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28905882","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/a35ed439-1699-4619-882d-410e5e650555","type":"EvidenceLine","dc:description":"Splice site variants were maxed at 1.5 pts regardless of functional evidence","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a35ed439-1699-4619-882d-410e5e650555_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Restriction enzyme digest analysis showed no or extremely reduced mature transcript","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a35ed439-1699-4619-882d-410e5e650555_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28905882","allele":{"id":"https://genegraph.clinicalgenome.org/r/73d8222c-ccc1-4d50-a921-ff91eafb9117"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/adb8e5af-4829-4d9e-9897-154b4c27370e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28905882","rdfs:label":"Goos family 1 III.2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":37,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/8f0d7fa8-4211-48b1-b5f5-5799b464a047"},{"id":"https://genegraph.clinicalgenome.org/r/73d8222c-ccc1-4d50-a921-ff91eafb9117"}],"detectionMethod":"SNP array, WGS, and MLPA","firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"Hypoplasia infra-orbital rim, longer eyelashes laterally than medially, microstrabismus, maxillary hypoplasia, normal psychomotor development","phenotypes":["obo:HP_0000652","obo:HP_0000347","obo:HP_0004502","obo:HP_0000384","obo:HP_0000646","obo:HP_0001092","obo:HP_0000567","obo:HP_0000324","obo:HP_0000582","obo:HP_0012745"],"secondTestingMethod":"Chromosomal microarray","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/a35ed439-1699-4619-882d-410e5e650555_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/cc838c5d-8ef0-4ac4-9ec7-62079f9354c6_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.75}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":10.6},{"id":"https://genegraph.clinicalgenome.org/r/bac99de0-8f34-4166-b8ef-a5c44290281c_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bac99de0-8f34-4166-b8ef-a5c44290281c_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/acf5316e-ad6b-4f10-bdd2-84dd8940d8f9","type":"EvidenceLine","dc:description":"Downgraded for the lack of replication/rescue of other phenotypes in the model. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d20952d1-446e-4b7b-b2d6-e2754e4a7ba9","type":"Finding","dc:description":"The modified version of Xenopus Txnl4a restored the proportion of normal embryos from 14% to 62%. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35893124","rdfs:label":"Rescue in MO-knockdown Xenopus","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/bac99de0-8f34-4166-b8ef-a5c44290281c_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f0fd664-e4c5-4d34-91de-2adcde0ccae0","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02722155-d071-4b11-951a-451f35b8ca77","type":"FunctionalAlteration","dc:description":"BMKS patient-derived iPSCs exhibited slow proliferation rate and increased apoptosis as compared with both mother- and unrelated control-derived iPSCs, and RNA-Seq analysis revealed significant differences in gene expression and alternative splicing. Patient iPSCs displayed defective differentiation into iNCCs compared to maternal and unrelated control iPSCs, in particular a delay in undergoing an epithelial-to-mesenchymal transition (EMT), a fundamental process for the dissemination of neural crest cells in the embryo. RNA-Seq analysis of differentiated iNCCs revealed widespread gene expression changes and mis-splicing in genes relevant to craniofacial and embryonic development that highlight a dampened response to WNT signalling, the key pathway activated during iNCC differentiation\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32735620","rdfs:label":"Functional alteration in patient iPSCs"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b85efeb8-1a7b-4383-8e14-b3f09a94674d","type":"EvidenceLine","dc:description":"Since this is a yeast ortholog assay, it was downgraded to 0.25 ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95d5f8fd-a6ed-4d2d-96aa-5b3df2f85a89","type":"FunctionalAlteration","dc:description":"Depletion of DIB1 resulted in reduced assembly of the U4/U6⋅U5 tri-snRNP complex. DIB1 is highly homologous to TXNL4A, so it is likely that reduced expression of TXNL4A in humans would also cause reduced tri-snRNP assembly. This suggests that reduced tri-snRNP assembly influences the splicing of a specific subset of pre-mRNAs, resulting in the phenotypic spectrum associated with BMKS.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434003","rdfs:label":"Functional alteration in yeast ortholog"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.25}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.25}],"evidenceStrength":"Definitive","sequence":8123,"specifiedBy":"GeneValidityCriteria10","strengthScore":12.85,"subject":{"id":"https://genegraph.clinicalgenome.org/r/9TQqc4tfzIc","type":"GeneValidityProposition","disease":"obo:MONDO_0012064","gene":"hgnc:30551","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_bac99de0-8f34-4166-b8ef-a5c44290281c-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}